Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
Intraoperative near-infrared (NIR) fluorescence imaging is a technology with high potential to provide the surgeon with real-time visualization of tumors during surgery. Our study explores the feasibility for clinical translation of an epidermal growth factor receptor (EGFR)-targeting nanobody for intraoperative imaging and resection of orthotopic tongue tumors and cervical lymph node metastases. The anti-EGFR nanobody 7D12 and the negative control nanobody R2 were conjugated to the NIR fluorophore IRDye800CW (7D12-800CW and R2-800CW). Orthotopic tongue tumors were induced in nude mice using the OSC-19-luc2-cGFP cell line. Tumor-bearing mice were injected with 25 µg 7D12-800CW, R2-800CW or 11 µg 800CW. Subsequently, other mice were injected with 50 or 75 µg of 7D12-800CW. The FLARE imaging system and the IVIS spectrum were used to identify, delineate and resect the primary tumor and cervical lymph node metastases. All tumors could be clearly identified using 7D12-800CW. A significantly higher tumor-to-background ratio (TBR) was observed in mice injected with 7D12-800CW compared to mice injected with R2-800CW and 800CW. The highest average TBR (2.00 ± 0.34 and 2.72 ± 0.17 for FLARE and IVIS spectrum, respectively) was observed 24 hr after administration of the EGFR-specific nanobody. After injection of 75 µg 7D12-800CW cervical lymph node metastases could be clearly detected. Orthotopic tongue tumors and cervical lymph node metastases in a mouse model were clearly identified intraoperatively using a recently developed fluorescent EGFR-targeting nanobody. Translation of this approach to the clinic would potentially improve the rate of radical surgical resections.
Department of Radiology and Molecular Imaging, Leiden University Medical Center, Leiden, The Netherlands; Percuros B.V., Enschede, The Netherlands.
P B A A
PB
van Driel
J R
JR
van der Vorst
F P R
FP
Verbeek
S
S
Oliveira
T J A
TJ
Snoeks
S
S
Keereweer
B
B
Chan
M C
MC
Boonstra
J V
JV
Frangioni
P M P
PM
van Bergen en Henegouwen
A L
AL
Vahrmeijer
C W G M
CW
Lowik
D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D005260:Female; D005456:Fluorescent Dyes; D006258:Head and Neck Neoplasms / Q000473:pathology* / Q000601:surgery; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007430:Intraoperative Care; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D008856:Microscopy, Fluorescence; D053758:Nanoparticles / Q000737:chemistry*; D014062:Tongue Neoplasms / Q000473:pathology* / Q000601:surgery; D014407:Tumor Cells, Cultured
D061067:Antibodies, Monoclonal, Humanized; D005456:Fluorescent Dyes; C512478:EGFR protein, human; D066246:ErbB Receptors
epidermal growth factor receptor; image-guided surgery; nanobody; near-infrared fluorescence; oral squamous cell carcinoma